Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 07-2025 | 04-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 213,768 | 229,342 | 243,497 | 124,304 | 131,615 |
| Marketable Securities | 71,262 | 70,872 | 65,661 | 67,161 | 89,002 |
| Receivables | 17,327 | 8,793 | 7,122 | 2,487 | 1,383 |
| Inventories | 4,002 | 3,428 | 458 | N/A | N/A |
| TOTAL | $314,205 | $320,147 | $325,226 | $205,896 | $241,690 |
| Non-Current Assets | |||||
| PPE Net | 2,841 | 3,034 | 3,190 | 2,067 | 1,988 |
| Other Non-Current Assets | 11,871 | 12,194 | 11,515 | 7,542 | 7,092 |
| TOTAL | $14,712 | $15,228 | $14,705 | $9,609 | $9,080 |
| Total Assets | $328,917 | $335,375 | $339,931 | $215,505 | $250,770 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,045 | 8,268 | 8,074 | 5,869 | 4,883 |
| Accrued Expenses | 34,022 | 33,897 | 20,767 | 18,971 | 27,307 |
| Other current liabilities | 16,226 | 13,569 | 3,287 | N/A | N/A |
| TOTAL | $60,817 | $57,355 | $45,069 | $38,375 | $45,167 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 833 | N/A | 11,512 | 11,413 | 11,000 |
| Other Non-Current Liabilities | 266,395 | 269,017 | 277,863 | 136,340 | 110,212 |
| TOTAL | $287,752 | $280,731 | $277,863 | $136,340 | $110,212 |
| Total Liabilities | $348,569 | $338,086 | $322,932 | $174,715 | $155,379 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,241 | N/A | 50,546 | 50,523 | N/A |
| Common Shares | 51 | 51 | 50 | 50 | 50 |
| Retained earnings | -786,181 | -762,694 | -739,098 | -713,266 | -653,170 |
| Other shareholders' equity | -7,116 | -7,129 | -6,729 | -6,387 | -5,214 |
| TOTAL | $-19,652 | $-2,711 | $16,999 | $40,790 | $95,391 |
| Total Liabilities And Equity | $328,917 | $335,375 | $339,931 | $215,505 | $250,770 |